Angiogenic Factor with G-patch and FHA Domain 1 (AGGF1) Expression in Human Vascular Lesions

被引:10
作者
Zhan, Maosheng [1 ]
Hori, Yumiko [1 ]
Wada, Naoki [1 ]
Ikeda, Jun-ichiro [1 ]
Hata, Yuuki [2 ]
Osuga, Keigo [3 ]
Morii, Eiichi [1 ]
机构
[1] Osaka Univ, Grad Sch Med, Dept Pathol, Yamada Oka 2-2, Suita, Osaka 5650871, Japan
[2] Osaka Univ, Grad Sch Med, Dept Plast Surg, Yamada Oka 2-2, Suita, Osaka 5650871, Japan
[3] Osaka Univ, Grad Sch Med, Dept Radiol, Yamada Oka 2-2, Suita, Osaka 5650871, Japan
关键词
AGGF1; vascular malformation; vascular tumor; mast cell; KLIPPEL-TRENAUNAY-SYNDROME; BLOOD-VESSEL FORMATION; GROWTH;
D O I
10.1267/ahc.15035
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Angiogenic factor with G-patch and FHA domain 1 (AGGF1) is a novel angiogenic factor that was first described in Klippel-Trenaunay syndrome, a congenital vascular disease associated with capillary and venous malformations. AGGF1, similar to vascular endothelial growth factor (VEGF), has been shown to promote strong angiogenesis in chick embryos in vivo. Blocking AGGF1 expression prevented vessel formation, which suggests AGGF1 is a potent angiogenic factor linked to vascular malformations. So far, AGGF1 expression studies in human vascular lesions have not been performed. Here, we immunohistochemically investigated AGGF1 expression in venous, arteriovenous or capillary malformations, and infantile or congenital hemangioma. We found that AGGF1 was mostly expressed in endothelial cells with plump morphology. Moreover, the majority of mast cells strongly expressed AGGF1. Notwithstanding our incomplete knowledge of the molecular mechanism of AGGF1 in angiogenesis, our results show for the first time that AGGF1 is expressed in plump endothelial cells and mast cells.
引用
收藏
页码:75 / 81
页数:7
相关论文
共 21 条
[1]  
Berry SA, 1998, AM J MED GENET, V79, P319, DOI 10.1002/(SICI)1096-8628(19981002)79:4<319::AID-AJMG15>3.0.CO
[2]  
2-U
[3]   OCRE: a novel domain made of imperfect, aromatic-rich octamer repeats [J].
Callebaut, I ;
Mornon, JP .
BIOINFORMATICS, 2005, 21 (06) :699-702
[4]   Angiogenesis in cancer and other diseases [J].
Carmeliet, P ;
Jain, RK .
NATURE, 2000, 407 (6801) :249-257
[5]   Angiogenesis in health and disease [J].
Carmeliet, P .
NATURE MEDICINE, 2003, 9 (06) :653-660
[6]   Functional characterization of KlippelTrenaunay syndrome gene AGGF1 identifies a novel angiogenic signaling pathway for specification of vein differentiation and angiogenesis during embryogenesis [J].
Chen, Di ;
Li, Lei ;
Tu, Xin ;
Yin, Zhan ;
Wang, Qing .
HUMAN MOLECULAR GENETICS, 2013, 22 (05) :963-976
[7]   Vascular Anomalies and Lymphedema [J].
Chim, Harvey ;
Drolet, Beth ;
Duffy, Kelly ;
Koshima, Isao ;
Gosain, Arun K. .
PLASTIC AND RECONSTRUCTIVE SURGERY, 2010, 126 (02) :55E-69E
[8]   Vascular endothelial growth factors synthesized by human lung mast cells exert angiogenic effects [J].
Detoraki, Aikaterini ;
Staiano, Rosaria I. ;
Granata, Francescopaolo ;
Giannattasio, Giorgio ;
Prevete, Nella ;
de Paulis, Amato ;
Ribatti, Domenico ;
Genovese, Arturo ;
Triggiani, Massimo ;
Marone, Gianni .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 123 (05) :1142-1149
[9]   ANGIOGENESIS IN REPRODUCTIVE TISSUES [J].
FINDLAY, JK .
JOURNAL OF ENDOCRINOLOGY, 1986, 111 (03) :357-366
[10]  
FOLKMAN J, 1963, CANCER, V16, P453, DOI 10.1002/1097-0142(196304)16:4<453::AID-CNCR2820160407>3.0.CO